Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 36 results.
User Information
Export Records
  1. 1.   Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors
  2. Krushkal, Julia; Zhao, Yingdong; Roney, Kyle; Zhu, Weimin; Brooks,Alan; Wilsker,Deborah; Parchment, Ralph E; McShane, Lisa M; Doroshow, James H
  3. Epigenetics. 2024, Dec; 19(1): 2309824.
  1. 2.   Synthesis and Biological Evaluation of Novel 2-Aroyl Benzofuran-Based Hydroxamic Acids as Antimicrotubule Agents
  2. Mariotto, Elena; Canton, Martina; Marchioro, Chiara; Brancale, Andrea; Hamel,Ernest; Varani, Katia; Vincenzi, Fabrizio; De Ventura, Tiziano; Padroni, Chiara; Viola, Giampietro; Romagnoli, Romeo
  3. International Journal of Molecular Sciences. 2024, Jul 09; 25(14):
  1. 3.   Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations
  2. Winckelmann, Anni; Barton, Kirston; Hiener, Bonnie; Schlub, Timothy E.; Shao, Wei; Rasmussen, Thomas A.; Ostergaard, Lars; Sogaard, Ole S.; Tolstrup, Martin; Palmer, Sarah
  3. AIDS. 2017, Mar 27; 31(6): 771-779.
  1. 4.   EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
  2. Wang, C. X.; Liu, Z. H.; Woo, C. W.; Li, Z. J.; Wang, L. F.; Wei, J. S.; Marquez, V. E.; Bates, S. E.; Jin, Q. H.; Khan, J.; Ge, K.; Thiele, C. J.
  3. Cancer Research. 2012, Jan; 72(1): 315-324.
  1. 5.   Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2
  2. Huang, W. Y.; Yang, P. M.; Chang, Y. F.; Marquez, V. E.; Chen, C. C.
  3. Biochemical Pharmacology. 2011, Feb; 81(4): 510-517.
  1. 6.   Identification of Four Potential Epigenetic Modulators from the NCI Structural Diversity Library Using a Cell-Based Assay
  2. Best, A. M.; Chang, J. J.; Dull, A. B.; Beutler, J. A.; Martinez, E. D.
  3. Journal of Biomedicine and Biotechnology. 2011 11.
  1. 7.   Total Synthesis and Biological Evaluation of Largazole and Derivatives with Promising Selectivity for Cancers Cells
  2. Zeng, X.; Yin, B. L.; Hu, Z.; Liao, C. Z.; Liu, J. L.; Li, S.; Li, Z.; Nicklaus, M. C.; Zhou, G. B.; Jiang, S.
  3. Organic Letters. 2010, Mar; 12(6): 1368-1371.
  1. 8.   Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
  2. Bates, S. E.; Zhan, Z. R.; Steadman, K.; Obrzut, T.; Luchenko, V.; Frye, R.; Robey, R. W.; Turner, M.; Gardner, E. R.; Figg, W. D.; Steinberg, S. M.; Ling, A.; Fojo, T.; To, K. W.; Piekarz, R. L.
  3. British Journal of Haematology. 2010, Jan; 148(2): 256-267.
  1. 9.   Epigenetic gene regulation in stem cells and correlation to cancer
  2. Mathews, L. A.; Crea, F.; Farrar, W. L.
  3. Differentiation. 2009, Jul; 78(1): 1-17.
  1. 10.   Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts
  2. Baschnagel, A.; Russo, A.; Burgan, W. E.; Carter, D.; Beam, K.; Palmieri, D.; Steeg, P. S.; Tofilon, P.; Camphausen, K.
  3. Molecular Cancer Therapeutics. 2009 8(6): 1589-1595.
  1. 11.   Determination of a benzamide histone deacetylase inhibitor, MS-275, in human plasma by liquid chromatography with mass-spectrometric detection
  2. Danish, M.; Gardner, E. R.; Chen, X. H.; Figg, W. D.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2009 877(3): 355-359.
  1. 12.   Diverse roles of HP1 proteins in heterochromatin assembly and functions in fission yeast
  2. Fischer, T.; Cui, B. W.; Dhakshnamoorthy, J.; Zhou, M.; Rubin, C.; Zofall, M.; Veenstra, T. D.; Grewal, S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(22): 8998-9003.
  1. 13.   Bioactive Food Components, Inflammatory Targets, and Cancer Prevention
  2. Kim, Y. S.; Young, M. R.; Bobe, G.; Colburn, N. H.; Milner, J. A.
  3. Cancer Prevention Research. 2009 2(3): 200-208.
  1. 14.   The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo
  2. Lucas, D. M.; Edwards, R. B.; Lozanski, G.; West, D. A.; Shin, J. D.; Vargo, M. A.; Davis, M. E.; Rozewski, D. M.; Johnson, A. J.; Su, B. N.; Goettl, V. M.; Heerema, N. A.; Lin, T. S.; Lehman, A.; Zhang, X. L.; Jarjoura, D.; Newman, D. J.; Byrd, J. C.
  3. Blood. 2009 113(19): 4656-4666.
  1. 15.   Gene expression-signature of belinostat in cell lines is specific for histone deacetylase inhibitor treatment, with a corresponding signature in xenografts
  2. Monks, A.; Hose, C. D.; Pezzoli, P.; Kondapaka, S.; Vansant, G.; Petersen, K. D.; Sehested, M.; Monforte, J.; Shoemaker, R. H.
  3. Anti-Cancer Drugs. 2009 20(8): 682-692.
  1. 16.   Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
  2. Palmieri, D.; Lockman, P. R.; Thomas, F. C.; Hua, E.; Herring, J.; Hargrave, E.; Johnson, M.; Flores, N.; Qian, Y. Z.; Vega-Valle, E.; Taskar, K. S.; Rudraraju, V.; Mittapalli, R. K.; Gaasch, J. A.; Bohn, K. A.; Thorsheim, H. R.; Liewehr, D. J.
  3. Clinical Cancer Research. 2009 15(19): 6148-6157.
  1. 17.   Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma
  2. Woo, S.; Gardner, E. R.; Chen, X. H.; Ockers, S. B.; Baum, C. E.; Sissung, T. M.; Price, D. K.; Frye, R.; Piekarz, R. L.; Bates, S. E.; Figg, W. D.
  3. Clinical Cancer Research. 2009 15(4): 1496-1503.
  1. 18.   Determination of the cyclic depsipeptide FK228 in human and mouse plasma by liquid chromatography with mass-spectrometric detection
  2. Chen, X. H.; Gardner, E. R.; Figg, W. D.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2008 865(1-2): 153-158.
  1. 19.   The heavy metal cadmium induces valosin-containing protein (VCP)-mediated aggresome formation
  2. Song, C. C.; Xiao, Z.; Nagashima, K.; Li, C.; Lockett, S. J.; Dai, R. M.; Cho, E. H.; Conrads, T. P.; Veenstra, T. D.; Colburn, N. H.; Wang, Q.; Wang, J. M.
  3. Toxicology and Applied Pharmacology. 2008 228(3): 351-363.
  1. 20.   Zap70 signaling pathway mediates glucocorticoid receptor-dependent transcriptional activation: role in the regulation of annexin 1 expression in T cells
  2. Ishaq, M.; DeGray, G.; Mou, K.; Aguilera, A.; Yang, J.; Lempicki, R. A.; Hazen, A.; Natarajan, V.
  3. Journal of Immunology. 2007, Sep; 179(6): 3851-3858.
  1. 21.   Pathway analysis identifies perturbation of genetic networks induced by butyrate in a bovine kidney epithelial cell line
  2. Li, C. J.; Li, R. W.; Wang, Y. H.; Elsasser, T. H.
  3. Functional & Integrative Genomics. 2007, Jul; 7(3): 193-205.
  1. 22.   Structure of the POZ domain of human LRF, a master regulator of oncogenesis
  2. Schubot, F. D.; Tropea, J. E.; Waugh, D. S.
  3. Biochemical and Biophysical Research Communications. 2006, Dec; 351(1): 1-6.
  1. 23.   Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration
  2. Melcon, G.; Kozlov, S.; Cutler, D. A.; Sullivan, T.; Hernandez, L.; Zhao, P.; Mitchell, S.; Nader, G.; Bakay, M.; Rottman, J. N.; Hoffman, E. P.; Stewart, C. L.
  3. Human Molecular Genetics. 2006, FEB 15; 15(4): 637-651.
  1. 24.   Gene profiling of PXD-101, a novel hydroxamate type inhibitor of histone deacetylase, leads to identification of aurora kinase inhibition
  2. Hose, C.; Shoemaker, R.; Monks, A.
  3. Clinical Cancer Research. 2005, DEC 15; 11(24, Part 2 Suppl. S): 9152S-9152S.
  1. 25.   Antibody response to a non-conserved C-terminal part of human histone deacetylase 3 in colon cancer patients
  2. Shebzukhov, Y. V.; Koroleva, E. P.; Khlgatian, S. V.; Belousov, P. V.; Kuz'mina, K. E.; Radko, B. V.; Longpre, F.; Lagarkova, M. A.; Kadachigova, T. S.; Gurova, O. V.; Meshcheryakov, A. A.; Lichinitser, M. R.; Knuth, A.; Jager, E.; Kuprash, D. V.; Nedospasov, S. A.
  3. International Journal of Cancer. 2005, DEC 10; 117(5): 800-806.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel